To analyze the relationship between HNRNPA2B1 and cancer progression, we calculated HNRNPA2B1 expression in different WHO cancer clinical stages in each cancer, we observed significant differences in four tumors (Supplementary figure 1), such as LUSC, LIHC, TGCT, and ACC. Here, HNRNPA2B1 is linked to cancer.